IZOZF
Izotropic Corporation·Healthcare
0.17
7.595%(+0.01)
Close PriceLast Updated: — ET
52W L: $0.1252W H: $0.37
IZOZF NEWS
newsfilecorp.com
Feb 25
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18th announcement regarding the formation "Izotropic Africa" under a Letter Agreement, the proposed Casablanca-based entity has entered into partnership discussions with the Mohammed VI Foundation for Science & Health ("FM6SS"). The FM6SS operates as a public utility institution under the patronage of King Mohammed VI, supporting healthcare reform, research advancement, innovation, and institutional partnerships within Morocco.
newsfilecorp.com
Feb 18
Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 18, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a Letter Agreement (the "Agreement") with a business group ("BG") to establish an entity named Izotropic Africa (the "Entity") based in Casablanca, Morocco. The Entity is intended to license, market, distribute, and evaluate manufacturing and/or assembly of IzoView Breast CT and certain follow-on products in all of Africa and the Gulf Cooperation Council ("GCC"): Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates (the "Business Purpose").
newsfilecorp.com
Feb 4
Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 4, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that further to its January 28, 2026 announcement it has completed a non-brokered private placement financing (the "Offering"), and that is has entered into a debt settlement agreement (the "Agreement") with a lender (the "Lender") to settle outstanding interest payable pursuant to a promissory note originally issued by the Company. In connection with the closing of the Offering, the Company issued 1,200,000 units (each, a "Private Placement Unit") at a price of $0.25 per Unit for gross proceeds of $300,000.
newsfilecorp.com
Jan 28
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - January 28, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, provides a corporate update and announces the intention to complete a small non-brokered private placement financing. The Company's primary objective is securing capital financing to fund the commercialization of IzoView Breast CT, including prioritizing non-dilutive options, while actively evaluating opportunities to expedite additional regulatory pathways and positioning for earlier revenue generation.
defenseworld.net
Jan 25
Izotropic (OTCMKTS:IZOZF) Sets New 1-Year High – Here’s What Happened
Shares of Izotropic Corporation (OTCMKTS:IZOZF - Get Free Report) reached a new 52-week high during mid-day trading on Friday. The company traded as high as $214,748.3647 and last traded at $214,748.3647, with a volume of 9100 shares traded. The stock had previously closed at $0.1882. Izotropic Price Performance The business has a 50-day moving
